Navigation Links
Eurofins MWG Operon signs contract to supply DNA sequencing services to Research Councils
Date:1/17/2011

Ebersberg, Germany, January 17, 2011 Eurofins MWG Operon, international market leader and expert for DNA sequencing, has signed a 2-year contract to supply DNA sequencing services to the Research Councils UK Shared Services Ltd (RCUK SSC Ltd). The contract may be extended to 3 years, and builds on a 5-year relationship developed as a preferred supplier of synthetic DNA and RNA oligonucleotides to the Research Councils.

RCUK SSC Ltd has been set up by the seven Research Councils of the UK (RCUK) to provide centralised services to the Research Councils and their institutes in human resources (HR), finance, procurement, Information Technology, Information Systems and grants processing. The shared service approach reduces costs whilst raising operational efficiency for the Councils.

"We are pleased to have the opportunity to further develop our relationship with RCUK. This contract will allow us to demonstrate our competence and strength in genomic services beyond the provision of synthetic DNA and RNA oligonucleotides", says Bruno Poddevin, Eurofins Senior Vice President, Genomic Services. "The synergies across our service offerings allow us to optimize our client service, from ordering convenience, to streamlined processes, through to faster turnaround time."

Richard Fowles, Category Manager at RCUK SSC Ltd commented, "RCUK SSC Ltd is pleased to announce the selection of Eurofins as one of its preferred suppliers of DNA sequencing services. Eurofins is already a proven supplier of oligos and we believe this new contract will afford them opportunities to further enhance their already strong reputation."

Eurofins MWG Operon also provides best in class next generation sequencing services, siRNA and gene synthesis services and is committed to continually optimizing and improving processes and product quality to ensure that they deliver their products and services in the fastest and most convenient manner possible.


'/>"/>

Contact: Dr. Jutta Huber
juttahuber@eurofins.com
49-809-282-89930
Eurofins MWG Operon
Source:Eurekalert

Page: 1

Related biology news :

1. Eurofins MWG Operon adds Roche GS Junior to its sequencer fleet
2. Eurofins MWG Operon signs contract to supply oligonucleotides to Research Councils
3. Eurofins MWG Operon and Genomatix developed most complete human exome array
4. Eurofins MWG Operon and Genomatix launch strategic alliance
5. Verizon Business to Provide Global IP for Eurofins Scientific
6. Reading the signs: Plants and animals found common ground in response to microbial threats
7. China PharmaHub Signs Distribution Agreement with Integrated Biometrics
8. Studying the metabolome of smokers, Lombardi researchers find early signs of damage
9. Speed installation of system to monitor vital signs of global ocean, scientists urge
10. SailPoint Signs International Reseller Agreement with BMC Software
11. Road signs and traffic signals on DNA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/3/2016)... , February 3, 2016 ... market research report "Automated Fingerprint Identification System Market by ... Search), Application (Banking & Finance, Government, Healthcare, and Transportation) ... MarketsandMarkets, the market is expected to be worth USD ... 21.0% between 2015 and 2020. The transformation and technology ...
(Date:2/2/2016)... 2016  BioMEMS devices deployed in hospitals ... medical screening and diagnostic applications, such as ... that facilitate and assure continuous monitoring without ... being bolstered through new opportunities offered by ... coupled with wireless connectivity and low power ...
(Date:2/2/2016)... YORK , Feb. 2, 2016 Technology Enhancements ... presents an analysis of the digital and computed radiography ... Malaysia , and Indonesia ... trends and market size, as well as regional market ... country and discusses market penetration and market attractiveness, both ...
Breaking Biology News(10 mins):
(Date:2/4/2016)... LEXINGTON, Massachusetts , February 4, 2016 - New ... --> - New FDA action date of July ... date of July 22, 2016   - ... the U.S. in the past decade indicated for the treatment of signs and ... Lifitegrast has the potential to be the only product approved in the ...
(Date:2/4/2016)... 4, 2016  CytoSorbents Corporation (NASDAQ: CTSO ... flagship CytoSorb® blood filter to treat deadly inflammation ... world, announced that CEO Dr. Phillip Chan ... Capital Group,s 2016 Disruptive Growth & Healthcare Conference, ... Conference Presentation Details: Where: Convene ...
(Date:2/4/2016)... Feb. 4, 2016 Sinovac Biotech Ltd. ("Sinovac" ... provider of biopharmaceutical products in China ... board of directors received on February 4, 2016 a ... a consortium comprised of PKU V-Ming ( Shanghai ... Ltd., CICC Qianhai Development ( Shenzhen ) ...
(Date:2/3/2016)... 2016  Discovery Laboratories, Inc. (NASDAQ: DSCO ... KL4 surfactant therapies for respiratory diseases, today announced ... inducement award as a component of employment compensation ... President and Chief Executive Officer.  The award was ... 1, 2016 and granted as an inducement material ...
Breaking Biology Technology: